文献速递临床试验与 GCP

BrainACT研究:接纳承诺疗法干预获得性脑损伤后抑郁焦虑症状的随机对照试验方案

The BrainACT study: acceptance and commitment therapy for depressive and anxiety symptoms following acquired brain injury: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-12-27

本研究为多中心、随机、对照、双臂平行试验,计划纳入94例卒中或创伤性脑损伤后存在焦虑和/或抑郁症状的患者,随机分配至接纳承诺疗法(ACT)组或对照(心理教育及放松)组。主要结局指标为医院焦虑抑郁量表和抑郁焦虑压力量表,由盲法评估者在治疗前、治疗中、治疗后及7、12个月随访时评估。

要点

  • ACT旨在提升心理灵活性而非直接减症,可能适合脑损伤后情绪障碍。
  • 研究采用盲法评估者、多中心随机对照设计,随访至12个月。
  • 若有效,BrainACT可推广至获得性脑损伤后焦虑抑郁的临床管理。

核心结论

  • 研究将评估 adapted ACT(BrainACT)对获得性脑损伤后焦虑和/或抑郁症状的有效性。
  • 若有效,BrainACT可融入临床实践并惠及大量获得性脑损伤患者。

研究设计与样本

  • 多中心、随机、对照、双臂平行试验,计划纳入94例卒中或创伤性脑损伤幸存者。
  • 患者随机分配至ACT干预组或对照(心理教育及放松)组。

关键数值与推荐

  • 主要结局指标为医院焦虑抑郁量表和抑郁焦虑压力量表。
  • 由训练有素的盲法评估者在治疗前、治疗中、治疗后及7、12个月时评估结局。

临床怎么用

  • BrainACT作为接纳承诺疗法改编方案,若试验证实有效,可考虑用于获得性脑损伤后焦虑抑郁症状的临床干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Following an acquired brain injury, individuals frequently experience anxiety and/or depressive symptoms. However, current treatments for these symptoms are not very effective. A promising treatment is acceptance and commitment therapy (ACT), which is a third-wave behavioural therapy. The primary goal of this therapy is not to reduce symptoms, but to improve psychological flexibility and general well-being, which may be accompanied by a reduction in symptom severity. The aim of this study is to investigate the effectiveness of an adapted ACT intervention (BrainACT) in people with acquired brain injury who experience anxiety and/or depressive symptoms. METHODS: The study is a multicenter, randomized, controlled, two-arm parallel trial. In total, 94 patients who survive a stroke or traumatic brain injury will be randomized into an ACT or control (i.e. psycho-education and relaxation) intervention. The primary outcome measures are the Hospital Anxiety and Depression Scale and the Depression Anxiety Stress Scale. Outcomes will be assessed by trained assessors, blinded to treatment condition, pre-treatment, during treatment, post-treatment, and at 7 and 12 months. DISCUSSION: This study will contribute to the existing knowledge on how to treat psychological distress following acquired brain injury. If effective, BrainACT could be implemented in clinical practice and potentially help a large number of patients with acquired brain injury. TRIAL REGISTRATION: Dutch Trial Register, NL691, NTR 7111. Registered on 26 March 2018. https://www.trialregister.nl/trial/6916.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Rauwenhoff J, Peeters F, Bol Y, et al. The BrainACT study: acceptance and commitment therapy for depressive and anxiety symptoms following acquired brain injury: study protocol for a randomized controlled trial. Trials. 2019. PMID: 31881916. doi:10.1186/s13063-019-3952-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。